Selleck Chemicals - Model A2045 -Vedolizumab (anti-α4β7-integrin)

Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.